Minawala Ria, Kim Michelle, Delau Olivia, Ghiasian Ghoncheh, McKenney Anna Sophia, Da Luz Moreira Andre, Chodosh Joshua, McAdams-DeMarco Mara, Segev Dorry L, Adhikari Samrachana, Dodson John, Shaukat Aasma, Dane Bari, Faye Adam S
Department of Medicine, NYU School of Medicine, New York, NY, USA.
Inflammatory Bowel Disease Center, Division of Gastroenterology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Inflamm Bowel Dis. 2025 Jun 13;31(6):1537-1547. doi: 10.1093/ibd/izae187.
Sarcopenia has been associated with adverse postoperative outcomes in older age cohorts, but has not been assessed in older adults with inflammatory bowel disease (IBD). Further, current assessments of sarcopenia among all aged individuals with IBD have used various measures of muscle mass as well as cutoffs to define its presence, leading to heterogeneous findings.
In this single-institution, multihospital retrospective study, we identified all patients aged 60 years and older with IBD who underwent disease-related intestinal resection between 2012 and 2022. Skeletal Muscle Index (SMI) and Total Psoas Index (TPI) were measured at the superior L3 endplate on preoperative computed tomography scans and compared through receiver operating characteristic curve. We then performed multivariable logistic regression to assess risk factors associated with an adverse 30-day postoperative outcome. Our primary outcome included a 30-day composite of postoperative mortality and complications, including infection, bleeding, cardiac event, cerebrovascular accident, acute kidney injury, venous thromboembolism, reoperation, all-cause rehospitalization, and need for intensive care unit-level care.
A total of 120 individuals were included. Overall, 52% were female, 40% had ulcerative colitis, 60% had Crohn's disease, and median age at time of surgery was 70 years (interquartile range: 65-75). Forty percent of older adults had an adverse 30-day postoperative outcome, including infection (23%), readmission (17%), acute kidney injury (13%), bleeding (13%), intensive care unit admission (10%), cardiac event (8%), venous thromboembolism (7%), reoperation (6%), mortality (5%), and cerebrovascular accident (2%). When evaluating the predictive performance of SMI vs TPI for an adverse 30-day postoperative event, SMI had a significantly higher area under the curve of 0.66 (95% CI, 0.56-0.76) as compared to 0.58 (95% CI, 0.48-0.69) for TPI (P = .02). On multivariable logistic regression, prior IBD-related surgery (adjusted odds ratio [adjOR] 6.46, 95% CI, 1.85-22.51) and preoperative sepsis (adjOR 5.74, 95% CI, 1.36-24.17) significantly increased the odds of adverse postoperative outcomes, whereas increasing SMI was associated with a decreased risk of an adverse postoperative outcome (adjOR 0.88, 95% CI, 0.82-0.94).
Sarcopenia, as measured by SMI, is associated with an increased risk of postoperative complications among older adults with IBD. Measurement of SMI from preoperative imaging can help risk stratify older adults with IBD undergoing intestinal resection.
肌肉减少症与老年人群术后不良结局相关,但尚未在老年炎症性肠病(IBD)患者中进行评估。此外,目前对所有年龄的IBD患者肌肉减少症的评估使用了各种肌肉量测量方法以及定义其存在的临界值,导致研究结果存在异质性。
在这项单机构、多医院的回顾性研究中,我们确定了2012年至2022年间所有年龄在60岁及以上、因IBD接受疾病相关肠道切除术的患者。在术前计算机断层扫描上于L3椎体上终板测量骨骼肌指数(SMI)和总腰大肌指数(TPI),并通过受试者工作特征曲线进行比较。然后我们进行多变量逻辑回归以评估与术后30天不良结局相关的危险因素。我们的主要结局包括术后30天的综合死亡率和并发症,包括感染、出血、心脏事件、脑血管意外、急性肾损伤、静脉血栓栓塞、再次手术、全因再住院以及重症监护病房级护理需求。
共纳入120例患者。总体而言,52%为女性,40%患有溃疡性结肠炎,60%患有克罗恩病,手术时的中位年龄为70岁(四分位间距:65 - 75岁)。40%的老年患者术后30天出现不良结局,包括感染(23%)、再次入院(17%)、急性肾损伤(13%)、出血(13%)、重症监护病房入院(10%)、心脏事件(8%)、静脉血栓栓塞(7%)、再次手术(6%)、死亡(5%)和脑血管意外(2%)。在评估SMI与TPI对术后30天不良事件的预测性能时,SMI的曲线下面积显著更高,为0.66(95%CI,0.56 - 0.76),而TPI为0.58(95%CI,0.48 - 0.69)(P = 0.02)。在多变量逻辑回归中,既往IBD相关手术(调整后的优势比[adjOR] 6.46,95%CI,1.85 - 22.51)和术前脓毒症(adjOR 5.74,95%CI,1.36 - 24.17)显著增加了术后不良结局的几率,而SMI增加与术后不良结局风险降低相关(adjOR 0.88,95%CI,0.82 - 0.94)。
通过SMI测量的肌肉减少症与老年IBD患者术后并发症风险增加相关。术前影像学测量SMI有助于对接受肠道切除术的老年IBD患者进行风险分层。